All News

pso.PsA_.NPF_.jpg

Upadacitinib Effective in Biologic Refractory Psoriatic Arthritis

Jack Cush, MD

The SELECT-PsA 2 trial was presented at the ACR meeting and recently published in Annals of Rheumatic Disease, shows that psoriatic arthritis (PsA) patients who have failed at least one biologic DMARD, did respond well to upadacitinib.

Read Article
doctor computer telehealth telemedicine

Medicare Physician Fee Schedule Final Rule Released

Jack Cush, MD

Centers for Medicare & Medicaid's CY 2021 Medicare Physician Fee Schedule final rule provides much-needed increases in Medicare reimbursement for the evaluation and management (E/M) services provided by rheumatologists and other cognitive care specialties to Medicare beneficiaries.

Read Article
podcast logo

RheumNow Podcast – Back Talk Listener Questions (12.04.20)

Jack Cush, MD

Dr Jack Cush takes questions from RheumNow listeners

Read Article
pregnant-776506__180.jpg

PIANO Study - Safety of Biologics in Pregnancy

Jack Cush, MD

The results of the long awaited PIANO study have been reported in the journal Gastroenterology, showing that pregnant women with IBD may safely receive biologic or thiopurine therapy throughout the pregnancy without substantial added risk to the unborn or mother.

Read Article
cost.healthcare.jpg

Colchicine Approval Took a Huge Toll on CMS

Colchicine, the old gout drug often cited as a cheap anti-inflammatory, hasn't been such a good deal since FDA approval, a study in JAMA Internal Medicine showed.

Read Article
Telemedicine.MD.Computer.phone (keep)

How are RA patients doing using telemedicine/virtual care?

Janet Pope, MD, MPH, FRCPC

Rheumatologists switched their practices overnight from primarily in person to nearly all virtual care as COVID-19 pandemic geared up in March 2020 and then to a blend of in person and virtual care. How are RA patients doing?

Read Article
ACR20 Podcast

ACR20 - Autoinflammatory & Still's Disease Panel

Jack Cush, MD

This podcast features a discussion of autoinflammatory and Still's disease abstracts from virtual ACR 2020. Dr. Jack Cush is joined by a panel of experts including Drs. Olga Petryna, Bella Metha and Michael Ombrello.

Read Article
podcast logo

RheumNow Podcast – ACR 2020 Epilogue (11.20.20)

Jack Cush, MD

Dr. Jack Cush reviews a few more ACR 2020 abstracts and presents a new plan to learn or take in ACR20 content.

Read Article
Roundup RHeum ACR

Rheumatology Round-Up with Drs. Kavanaugh & Cush

Jack Cush, MD

The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020. Watch now!


Read Article
#BestACR20Tweets RT @doctorRBC : Rheumatology reimbursement by CMS: ""If all goes well, in a few months, you will see a 16% increase in rheumatology."" - From ACR Advocacy Updates @RheumNow #ACR20 Abs#5M017

Dr. John Cush RheumNow ( View Tweet)

Check out our latest article from Dr. Janet Pope ( @Janetbirdope) How are RA patients doing using telemedicine/virtual care? https://t.co/YffT28OwgY https://t.co/xnAe3lKL8W

Links:

Dr. John Cush RheumNow ( View Tweet)
(if this is true) Shame on @expressScripts and forcing money driven biologic changes (from secukinumab to ixekizumab) upon patients and doctors. This is soooo wrong! https://t.co/DYKSItCbYL

Links:

Dr. John Cush RheumNow ( View Tweet)

#BestACR20Tweets RT @DrMiniDey : Study on #telehealth in #rheumatology patients in the US finds those with #comorbidities and high disease activity are most likely to take up remote consults. Abs#1962 #ACR20 @RheumNow https://t.co/8USU39mTPk https://t.co/ioT1b1x4IO

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Rachel Tate ( @uptoTate) reviews outpatient billing and coding pearls presented at a session at the #ACR20 meeting. https://t.co/66YbqXcncr https://t.co/PDdVKfNJYd

Links:

Dr. John Cush RheumNow ( View Tweet)
Check this out! Can PT-CDAI in Telemedicine be Used for Care in RA? Dr. Eric Dein ( @ejdein1) #ACR20 https://t.co/dAgYOFMMJC https://t.co/QV02h171yP

Links:

Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets RT @synovialjoints : About half (51%) of patients from the FORWARD registry in the US had at least one telehealth appointment during COVID-19 pandemic and most were satisfied with the appointment @RheumNow #ACR20 Abstr#1962 https://t.co/PEiucSItZq https://t.co/6vzIlQWjOP

Links:

Dr. John Cush RheumNow ( View Tweet)
from #ACR20 Dr. Abbey Abelson. There was reduction in hip fractures in the US until there was drop in reimbursement for DEXA/Bone Density. @ACRheum has been advocating on Capitol Hill to restore reimbursement. Bad policy harms, but good policy can save lives. #ACRambassador https://t.co/ARo762Vozp
Suleman Bhana, MD DrBhana ( View Tweet)
Telemedicine Studies: A Trainee’s Perspective by Mrinalini Dey ( @DrMiniDey ) COVID-19 has shifted face to face to consultations--an important change in rheumatology practice. #ACR20 https://t.co/T2iUwE7XUo https://t.co/AyQ6X2fOJA

Links:

Dr. John Cush RheumNow ( View Tweet)
Back in my clinic today at GMT (+5 EST) and applying the new knowledge from #ACR20 ran a hybrid clinic with face to face, telephone and video consultations all rolled into one. Now time to catch up with Day 4 of ACR Convergence with @RheumNow #virtual #hybrid

Dr. Antoni Chan synovialjoints ( View Tweet)

We as young physicians should start paying attention to our contracts-🤦‍♀️ takeaways 1-know your worth (see MGMA compensation yearly) 2-malpractive/ tail coverage 3-non-compete 4-termination clause 5-gurantee @RheumNow #ACR20 #5M036

Bella Mehta bella_mehta ( View Tweet)

How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×